Simfibrate is a fibric acid derivative and peroxisome proliferator-activated receptor alpha (PPARα) agonist primarily indicated for the management of hyperlipidemia and dyslipidemia by effectively lowering… Read more
Simfibrate is a fibric acid derivative and peroxisome proliferator-activated receptor alpha (PPARα) agonist primarily indicated for the management of hyperlipidemia and dyslipidemia by effectively lowering triglyceride levels. This category provides comprehensive access to high-quality reference standards for the Simfibrate active pharmaceutical ingredient, alongside its pharmacopeial and non-pharmacopeial impurities, potential metabolites, and stable isotope-labelled compounds. Pharmaceutical laboratories rely on these specialized materials to support rigorous analytical testing, facilitate accurate impurity profiling, and perform essential method validation and quality control procedures. By utilizing these precise reference materials, researchers and quality assurance teams can ensure the reliability of their analytical data throughout the drug development and manufacturing lifecycle, maintaining compliance with stringent regulatory standards for efficacy and safety.